FARE and CVS Pharmacy® continue to partner on Teal Pumpkin Project for a more inclusive Halloween

Go back to FARE and CVS Pharmacy® continue to partner on Teal Pumpkin Project for a more inclusive Halloween

TD Cowen Upgrades CVS Health (CVS) to Buy

October 4, 2024 5:30 AM EDT

TD Cowen analyst Charles Rhyee upgraded CVS Health (NYSE: CVS) from Hold to Buy with a price target of $85.00 (from $59.00).

The analyst comments "We upgrade CVS to Buy from Hold, post release of 2025 MA plan benefits, which show CVS saw meaningful reductions... More